We did a stranded RNA-seq library prep on a bacterial sample (Mycobacterium tuberculosis). When using this kit for human/mouse/fly, the correct strand is always "second" or "reverse" strand (different tools have different nomenclature). This time, I am getting 90% of the reads on the other strand. It doesn't make much sense to me that the reads would somehow be on the wrong strand. At worst, they should be 50/50. Do the bacterial annotations have different assumptions? Should I be concerned?
Unconfigured Ad
Collapse
X
-
Hi,
a lot of strand-specific RNA-Seq kits produce "reverse" reads. See http://seqanswers.com/forums/showthread.php?t=50459 and http://seqanswers.com/forums/showthread.php?t=50711.
I'd guess it is more a library-prep issue than an annotation issue; so I don't think you should be concerned.
-
-
I think you misunderstood my question. I am familiar with the kit and I've used it for other species many times. The reads are always "reverse". Now I did bacteria and they are not "reverse".Originally posted by Michael.Ante View PostHi,
a lot of strand-specific RNA-Seq kits produce "reverse" reads. See http://seqanswers.com/forums/showthread.php?t=50459 and http://seqanswers.com/forums/showthread.php?t=50711.
I'd guess it is more a library-prep issue than an annotation issue; so I don't think you should be concerned.
Comment
-
-
The kit is ScriptSeq Complete Gold Kit (http://www.illumina.com/products/scr...demiology.html). It even says on the website: "choose the FR=secondstrand option". That always works fine for me.Originally posted by pmiguel View PostWhat kit are you using?
Yes, if you use the same kit in the same way your strandedness should remain the same.
My first suspicion would be that the annotation for your Mycobacterium is wrong.
I am also concerned that the annotation is wrong, but I am using the references from Ensembl (http://bacteria.ensembl.org/mycobact..._2/Info/Index/). I assume their info would be consistent across all species. I never ran into any issues like this with non-bacterial references.
Comment
-
-
It would be odd to have entire genome annotation wrong from Ensembl (but strange things do happen). Are you using the GFF file Ensembl is providing?
Can you compare the annotation from NCBI: http://www.ncbi.nlm.nih.gov/genome/?...culosis+H37Rv?
Comment
-
-
When you write "This time, I am getting 90% of the reads on the other strand." what do you mean by "getting". I presume you use some program or browser to derive this figure? What program or browser did you use? Was it the same one you used for previous projects?
--
Phillip
Comment
-
-
I used the Ensembl GFF. I also tried the NCBI GFF. Similar result with both.Originally posted by GenoMax View PostIt would be odd to have entire genome annotation wrong from Ensembl (but strange things do happen). Are you using the GFF file Ensembl is providing?
Can you compare the annotation from NCBI: http://www.ncbi.nlm.nih.gov/genome/?...culosis+H37Rv?
I use Picard CollectRnaSeqMetrics to collect the stats. It also generates graphs for normalized coverage across transcript. Usually, the middle is much higher than the ends. With this RNA-seq, the ends are actually slightly higher.
It's really bizarre. I've never seen anything like this.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
Yesterday, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:04 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
7 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|
Comment